1. Anagrelide lot recalled in USA due to dissolution issue

   News item 04 June 2022 Pages: 1 - 1

2. COVID-19 vaccine-induced VITT/TSS in Malaysia

   News item 04 June 2022 Pages: 2 - 2

3. Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia

   News item 04 June 2022 Pages: 3 - 3

4. Lareb study on COVID-19 vaccine-related menstrual disorders

   News item 04 June 2022 Pages: 4 - 4

5. Itraconazole contaminated with rilmazafone in Japan

   Clinical study 04 June 2022 Pages: 5 - 5

6. Apalutamide-associated skin adverse events

   Clinical study 04 June 2022 Pages: 6 - 6

7. Chemotherapy-induced hand-and-foot syndrome

   Clinical study 04 June 2022 Pages: 7 - 7

8. Drugs associated with risk of amyotrophic lateral sclerosis

   Clinical study 04 June 2022 Pages: 8 - 8

9. Gemcitabine and nab-paclitaxel drug interaction?

   Clinical study 04 June 2022 Pages: 9 - 9

10. Low risk of myopericarditis after COVID-19 vaccination in children aged 5-11 years

    Clinical study 04 June 2022 Pages: 10 - 10

11. LTRA-related risk of neuropsychiatric events in paediatric patients

    Clinical study 04 June 2022 Pages: 11 - 11

12. Pfizer-BioNTech COVID-19 vaccine safe with clozapine

    Clinical study 04 June 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 04 June 2022 Pages: 13 - 13

14. Abatacept/immune-globulin

    Case report 04 June 2022 Pages: 14 - 14

15. Acenocoumarol

    Case report 04 June 2022 Pages: 15 - 15

16. Acenocoumarol

    Case report 04 June 2022 Pages: 16 - 16

17. Acetylcysteine/ascorbic-acid/methylprednisolone

    Case report 04 June 2022 Pages: 17 - 17

18. Aciclovir/tozinameran

    Case report 04 June 2022 Pages: 18 - 18

19. Ad26.COV2-S

    Case report 04 June 2022 Pages: 19 - 19

20. Ad26.CoV2-S/elasomeran

    Case report 04 June 2022 Pages: 20 - 20

21. Adalimumab

    Case report 04 June 2022 Pages: 21 - 21

22. Adalimumab/alteplase

    Case report 04 June 2022 Pages: 22 - 22

23. Adalimumab/mercaptopurine/mesalazine

    Case report 04 June 2022 Pages: 23 - 23

24. Adalimumab/methotrexate/prednisolone

    Case report 04 June 2022 Pages: 24 - 24

25. Adenosine-triphosphate

    Case report 04 June 2022 Pages: 25 - 25

26. Aflibercept

    Case report 04 June 2022 Pages: 26 - 26

27. Albumin-human/paracetamol

    Case report 04 June 2022 Pages: 27 - 27

28. Alemtuzumab

    Case report 04 June 2022 Pages: 28 - 28

29. Alendronic-acid

    Case report 04 June 2022 Pages: 29 - 29

30. Alendronic-acid

    Case report 04 June 2022 Pages: 30 - 30

31. Alendronic-acid

    Case report 04 June 2022 Pages: 31 - 31

32. Alendronic-acid/denosumab/zoledronic-acid

    Case report 04 June 2022 Pages: 32 - 33

33. Alteplase

    Case report 04 June 2022 Pages: 33 - 33

34. Alteplase/antihypertensives

    Case report 04 June 2022 Pages: 34 - 34

35. Amikacin/meropenem

    Case report 04 June 2022 Pages: 35 - 35

36. Aminolevulinic-acid

    Case report 04 June 2022 Pages: 36 - 36

37. Amiodarone

    Case report 04 June 2022 Pages: 37 - 37

38. Amiodarone

    Case report 04 June 2022 Pages: 38 - 38

39. Amiodarone

    Case report 04 June 2022 Pages: 39 - 39

40. Amiodarone/esmolol

    Case report 04 June 2022 Pages: 40 - 40

41. Amiodarone/thiamazole

    Case report 04 June 2022 Pages: 41 - 41

42. Amitriptyline/glibenclamide/sildenafil

    Case report 04 June 2022 Pages: 42 - 42

43. Amoxicillin/ibuprofen/paracetamol

    Case report 04 June 2022 Pages: 43 - 43

44. Amphotericin-B

    Case report 04 June 2022 Pages: 44 - 44

45. Amphotericin-B-liposomal

    Case report 04 June 2022 Pages: 45 - 45

46. Amphotericin-B-liposomal

    Case report 04 June 2022 Pages: 46 - 46

47. Analgesics

    Case report 04 June 2022 Pages: 47 - 47

48. Andexanet-alfa

    Case report 04 June 2022 Pages: 48 - 48

49. Anthracycline/trastuzumab

    Case report 04 June 2022 Pages: 49 - 49

50. Anti-inflammatories

    Case report 04 June 2022 Pages: 50 - 50